Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.22.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Net revenue:    
Total revenues $ 21,625 $ 914
Operating expenses    
Cost of sales 256 48
Selling, general and administrative 45,197 39,805
Research and development 12,620 9,833
Other expense, net 1,434 1,771
Total cost of sales and operating expenses 59,507 51,457
Loss from operations (37,882) (50,543)
Interest income 262 172
Net loss before income taxes (37,620) (50,371)
Income tax expense 10 8
Net loss (37,630) (50,379)
Other comprehensive loss:    
Unrealized (loss) gain on available-for-sale securities, net of tax of nil (766) 6
Comprehensive loss $ (38,396) $ (50,373)
Basic loss per share (expressed in $ per share) $ (0.27) $ (0.40)
Diluted loss per share (expressed in $ per share) $ (0.27) $ (0.40)
Weighted-average common shares outstanding used in computation of basic loss per share 141,675 127,401
Weighted-average common shares outstanding used in computation of diluted loss per share 141,675 127,401
Product revenue, net    
Net revenue:    
Total revenues $ 21,492 $ 884
License and collaboration revenue    
Net revenue:    
Total revenues $ 133 $ 30